用于新型冠状病毒核酸检测的即时检测方法研究进展

鲍瑶菲; 薛茜茹; 武海萍; 邹秉杰; 宋沁馨; 周国华

doi:10.11665/j.issn.1000-5048.20200601

用于新型冠状病毒核酸检测的即时检测方法研究进展

1.
中国药科大学药物质量与安全预警教育部重点实验室，南京 210009
2.
东部战区总医院临床药学科，南京 210002
3.
南方医科大学药学院，广州 510515

基金项目: 国家自然科学基金资助项目（No.81673390）；江苏省自然科学基金资助项目（No.BK20191322）；江苏省杰出青年基金资助项目（No.BK20180005）；大学生创新创业训练计划项目资助（No.202010316032S）

计量
- 文章访问数: 0756
- HTML全文浏览量: 0
- PDF下载量: 01822
出版历程
- 收稿日期: 2020-09-16
- 修回日期: 2020-11-08
- 刊出日期: 2020-12-24

Advances in point-of-care testing for new corona virus nucleic acid

Funds: This study was supported by the National Natural Science Foundation of China (No.81673390), the Natural Science Foundation of Jiangsu Province (No. BK20191322),the Jiangsu Provincial Science Fund for Distinguished Young Scholars (No.BK20180005) and the Undergraduate Training Programs for Innovation and Entrepreneurship(No.202010316032S)

摘要

摘要: 新型冠状病毒（SARS-CoV-2）引起的新型冠状病毒肺炎（corona virus disease 2019，COVID-19）在全世界范围内快速传播，截至2020年9月30日全球感染人数已达3 300万人，造成100多万人死亡，给公众的生命健康造成严重威胁。基于实验室的标准化核酸检测方法周转时间长、成本高，因此急需开发便捷检测新冠病毒的方法，实现在资源有限的情况下快速测试以及时控制疫情。本文从提取、扩增、检测3个方面总结了针对新型冠状病毒所开发的核酸即时检测方法（point-of-care testing，POCT），并对整合了这3个步骤的商业化即时检测装置进行简要介绍，以期为COVID-19及其他新兴传染病的紧急应对和快速部署提供参考。
- 新型冠状病毒 /
- 核酸检测 /
- 即时检测 /
- 进展
Abstract: The corona virus disease 2019 (COVID-19) caused by the new coronavirus (SARS-CoV-2) has spread rapidly around the world,posing a serious threat to the public"s health. As of September 30,2020,the number of infected people in the world has reached 33 million,causing more than 1 million deaths. Normalized nucleic acid detection methods based on lab have long turnaround time and high cost. Therefore,there is an urgent need to develop a convenient method to detect SARS-CoV-2,so as to achieve rapid testing and timely control of the epidemic when resources are limited.This review summarizes the point-of-care testing (POCT) methods developed for SARS-CoV-2 in terms of extraction,amplification and detection,and briefly introduces commercial POCT instruments that integrate these three steps,in order to provide references for emergency response and rapid deployment of COVID-19 and other emerging infectious diseases.
- SARS-CoV-2 /
- nucleic acid detection /
- point-of-care testing /
- advances

HTML全文

参考文献(43)

[1]	.Nature，2020，579（7798）：270?273.
[2]	Luppa PB，Müller C，Schlichtiger A，et al.Point-of-care testing （POCT）：current techniques and future perspectives［J］. Trends Analyt Chem，2011，30（6）：887?898.
[3]	To KK，Tsang OT，Yip CC，et al.Consistent detection of 2019 novel coronavirus in saliva［J］.Clin Infect Dis，2020，71（15）：841?843.
[4]	Lamb LE，Bartolone SN，Ward E，et al.Rapid detection of novel coronavirus/severe acute respiratory syndrome coronavirus 2 （SARS-CoV-2） by reverse transcription-loop-mediated isothermal amplification［J］.PLoS One，2020，15（6）：e0234682.
[5]	Vogels CBF，Brackney D，Wang J，et al.SalivaDirect：simple and sensitive molecular diagnostic test for SARS-CoV-2 surveillance［J］.medRxiv，2020：2020.08.03.20167791.
[6]	Rutgers.new Rutgers saliva test for Coronavirus gets FDA approval［EB/OL］.（2020-04-13）［2020-09-30］.https：//www. rutgers.edu/news/new-rutgers-saliva-test-coronavirus-gets-fda-approval.
[7]	To KKW，Tsang OTY，Leung WS，et al.Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2：an observational cohort study［J］. Lancet Infect Dis，2020，20（5）：565?574.
[8]	Zhao Z，Cui H，Song W，et al.A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2［J］.bioRxiv，2020：2020.02.22.961268.
[9]	Wee SK，Sivalingam SP，Yap EPH.Rapid direct nucleic acid amplification test without RNA extraction for SARS-CoV-2 using a portable PCR thermocycler［J］.Genes （Basel），2020，11 （6）：664.
[10]	Wei S，Kohl E，Djandji A，et al. Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction［J］. medRxiv，2020；2020.05.28.20115220.
[11]	Xia S，Chen X.Single-copy sensitive，field-deployable，and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA［J］.Cell Discov，2020，6：37.
[12]	Arumugam A，Faron ML，Yu P，et al.A rapid SARS-CoV-2 RT-PCR assay for low resource settings［J］.Diagnostics （Basel），2020，10（10）：739.
[13]	Yu L，Wu S，Hao X，et al.Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification （RT-LAMP） diagnostic platform［J］. Clin Chem，2020，66（7）：975?977.
[14]	Yang W，Dang X，Wang Q，et al.Rapid detection of SARS-CoV-2 using reverse transcription RT-LAMP method［J］.medRxiv，2020：2020.03.02.20030130.
[15]	Lu R，Wu X，Wan Z，et al.A novel reverse transcription loop-mediated isothermal amplification method for rapid detection of SARS-CoV-2［J］.Int J Mol Sci，2020，21（8）：2826.
[16]	Ganguli A，Mostafa A，Berger J，et al.Rapid isothermal amplification and portable detection system for SARS-CoV-2［J］. Proc Natl Acad Sci U S A，2020，117（37）：22727?22735.
[17]	Sun F，Ganguli A，Nguyen J，et al.Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract［J］. Lab Chip，2020，20（9）：1621?1627.
[18]	Gonzalez-Gonzalez E，Lara-Mayorga IM，Rodriguez-Sanchez IP，et al.Scaling diagnostics in times of COVID-19：colorimetric loop-mediated isothermal amplification （LAMP） assisted by a 3D-printed incubator for cost-effective and scalable detection of SARS-CoV-2［J］.medRxiv，2020：2020.04.09.20058651.
[19]	Behrmann O，Bachmann I，Spiegel M，et al.Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher （Exo-IQ）［J］.Clin Chem，2020，66（8）：1047?1054.
[20]	El-Tholoth M，Bau HH，Song J.A single and two-stage，closed-tube，molecular test for the 2019 novel coronavirus （COVID-19） at home，clinic，and points of entry［J］.ChemRxiv，2020. doi：10.26434/chemrxiv.11860137.
[21]	Van Ness J，Van Ness LK，Galas DJ.Isothermal reactions for the amplification of oligonucleotides［J］. Proc Natl Acad Sci U S A，2003，100（8）：4504?4509.
[22]	Park GS，Ku K，Baek SH，et al.Development of reverse transcription loop-mediated isothermal amplification assays targeting severe acute respiratory syndrome coronavirus 2 （SARS-CoV-2）［J］.J Mol Diagn，2020，22（6）：729?735.
[23]	Yan C，Cui J，Huang L，et al.Rapid and visual detection of 2019 novel coronavirus （SARS-CoV-2） by a reverse transcription loop-mediated isothermal amplification assay［J］.Clin Microbiol Infect，2020，26（6）：773?779.
[24]	Ganguli A，Mostafa A，Berger J，et al.Rapid isothermal amplification and portable detection system for SARS-CoV-2［J］.Proc Natl Acad Sci U S A，2020，117（37）：22727?22735.
[25]	Yang T，Wang YC，Shen CF，et al.Point-of-care RNA-based diagnostic device for COVID-19［J］.Diagnostics （Basel），2020，10（3）：165.
[26]	Moitra P，Alafeef M，Dighe K，et al.Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles［J］.ACS Nano，2020，14（6）：7617?7627.
[27]	Zhu X，Wang X，Han L，et al.Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19［J］. Biosens Bioelectron，2020，166：112437.
[28]	Gootenberg JS，Abudayyeh OO，Lee JW，et al.Nucleic acid detection with CRISPR-Cas13a/C2c2［J］.Science，2017，356（6336）：438?442.
[29]	Zhang F，Abudayyeh OO，Gootenberg JS.Protocol for detection of COVID-19 using CRISPR diagnostics［EB/OL］.（2020-03-21）［2020-09-30］.https：//www.broadinstitute.org/files/publications/special/COVID-19.
[30]	Hou T，Zeng W，Yang M，et al.Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19［J］.PLoS Pathog，2020，16（8）：e1008705.
[31]	Joung J，Ladha A，Saito M，et al. Point-of-care testing for COVID-19 using SHERLOCK diagnostics［J］. Preprint. medRxiv. 2020；2020.05.04.20091231.
[32]	Chen JS，Ma E，Harrington LB，et al.CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity［J］.Science，2018，360（6387 ）：436?439.
[33]	Huang Z，Tian D，Liu Y，et al.Ultra-sensitive and high-throughput CRISPR-powered COVID-19 diagnosis［J］.Biosens Bioelectron，2020，164：112316.
[34]	Lucia C，Federico PB，Alejandra GC.An ultrasensitive，rapid，and portable coronavirus SARS-CoV-2 sequence detection method based on CRISPR-Cas12［J］.bioRxiv，2020：2020.02.29.971127.
[35]	Broughton JP，Deng X，Yu G，et al.CRISPR-Cas12-based detection of SARS-CoV-2［J］.Nat Biotechnol，2020，38（7）：870?874.
[36]	Ding X，Yin K，Li Z，et al.Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay［J］.Nat Commun，2020，11（1）：4711.
[37]	Guo L，Sun X，Wang X，et al.SARS-CoV-2 detection with CRISPR diagnostics［J］.Cell Discov，2020，6：34.
[38]	FDA.Coronavirus Disease 2019 （COVID-19） EUA Information ［EB/OL］.（2020-05-11）［2020-09-30］.https：//www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidinvitrodev.
[39]	Moran A，Beavis KG，Matushek SM，et al.Detection of SARS-CoV-2 by use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 assays［J］. J Clin Microbiol，2020，58 （8）：e00772?20.
[40]	Hogan CA，Garamani N，Lee AS，et al.Comparison of the Accula SARS-CoV-2 test with a laboratory-developed assay for detection of SARS-CoV-2 RNA in clinical nasopharyngeal specimens［J］.J Clin Microbiol，2020，58 （8）：e01072?20.
[41]	NMPA：NMPA conducts emergency approvalof testing products for 2019-nCoV［EB/OL］.（2020-03-27）［2020-09-30］.https：//www.nmpa.gov.cn/ylqx/ylqxjgdt/20200.27182401511.html.
[42]	Mcdonald S，Courtney DM，Clark AE，et al.Diagnostic performance of a rapid point-of-care test for SARS-CoV-2 in an urban emergency department setting［J］.Acad Emerg Med，2020，10.1111/acem.14039.
[43]	Mitchell SL，George KS.Evaluation of the COVID19 ID NOW EUA assay［J］.J Clin Virol，2020，128：104429.